The DOI matches its Crossref record; 175 of the 177 references it cites were found in a registry or an index.
Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review
Open accessAbstract
Accumulating evidence regarding clinical, neurobiological, genetic, and environmental factors suggests a bidirectional link between obesity and depressive disorders. Although a few studies have investigated the link between obesity/excess body weight and the response to antidepressants in depressive disorders, the effect of weight on treatment response remains poorly understood. In this review, we summarized recent data regarding the relationship between the response to antidepressants and obesity/excess body weight in clinical studies of patients with depressive disorders. Although several studies indicated an association between obesity/excess body weight and poor antidepressant responses, it is difficult to draw definitive conclusions due to the variability of subject composition and methodological differences among studies. Especially, differences in sex, age and menopausal status, depressive symptom subtypes, and antidepressants administered may have caused inconsistencies in the results among studies. The relationship between obesity/excess body weight and antidepressant responses should be investigated further in high-powered studies addressing the differential effects on subject characteristics and treatment. Moreover, future research should focus on the roles of mediating factors, such as inflammatory markers and neurocognitive performance, which may alter the antidepressant treatment outcome in patients with comorbid obesity and depressive disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“In addition, adipose tissue macrophages may be a source of proinflammatory factors and can regulate the secretory activity of adipocytes [88].”
BackgroundChen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“Disruption of antidepressant induced hippocampal neurogenesis by selective irradiation of the hippocampus also blocked the antidepressant effects of fluoxetine and imipramine [140], suggesting that neurogenesis is fundamental in determining the functional consequences of antidepressant treatment [138].”
BackgroundEuropean Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188 · cited 1×
“, leptin, adiponectin, and resistin) [33–35].”
Adipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113 · cited 1×
“, leptin, adiponectin, and resistin) [33–35].”
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 7×
“This was found to be the case for serotonin 1A (5-HT1A) [121] and 5-HT1B [122] receptors, cannabinoid receptor subtype 1 (CB1R) [123], brain-derived neurotropic factor (BDNF) receptor, i.e., tropomyosin receptor kinase B (TrkB) [124–126], and the insulin receptor [104,127,128].”
BackgroundInfluentialFried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,528
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 1×
“The net result of these changes is loss of astrocytes and oligodendroglia and neuronal apoptosis, particularly in the subgenual prefrontal cortex, amygdala, and hippocampus, brain regions thought to be crucially involved in the genesis of the symptoms of depressive disorder [137].”
BackgroundAguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487 · cited 2×
“The PI3K/Akt/GSK3β pathway is also a key mechanism in the regulation of glucose transport and insulin metabolism in insulin-sensitive peripheral tissues [103,113,114].”
BackgroundThe Emergence of the Metabolic Syndrome with Menopause
Carr, M. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030242 · Cited by 1,449 · cited 1×
“Studies in postmenopausal women have shown a reversal of increased adipocytokines caused by increased visceral adiposity during menopause [40] with repletion of estrogen [41,42] and a specific anti-inflammatory action of estrogen on the brain [43,44].”
BackgroundFunctional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,371
Neuroimaging studies of mood disorders
Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,313 · cited 1×
“Recent studies suggested that these brain regions may also be related to antidepressant responses [67–70], and some of these brain regions overlapped with those showing a high insulin receptor density and mRNA expression levels [71–74].”
BackgroundDandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., & Garg, R. (2005) · Circulation · doi:10.1161/01.cir.0000158483.13093.9d · Cited by 1,263 · cited 1×
“Obesity is now considered to be a persistent, low-grade, proinflammatory state [86].”
BackgroundQuinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263 · cited 1×
“Increased levels of the neurotoxic tryptophan catabolite quinolinic acid cause excitotoxic neurodegenerative changes [145].”
BackgroundFried, S. K. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.847 · Cited by 1,145
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140 · cited 1×
“treatment resistance and in the mechanisms of action of antidepressants [152].”
BackgroundExcess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120 · cited 1×
“Recent studies suggested that these brain regions may also be related to antidepressant responses [67–70], and some of these brain regions overlapped with those showing a high insulin receptor density and mRNA expression levels [71–74].”
BackgroundHaroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
Microglial Activation and its Implications in the Brain Diseases
Thameem Dheen, S., Kaur, C., & Ling, E.-A. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780597961 · Cited by 952 · cited 1×
“Studies in postmenopausal women have shown a reversal of increased adipocytokines caused by increased visceral adiposity during menopause [40] with repletion of estrogen [41,42] and a specific anti-inflammatory action of estrogen on the brain [43,44].”
BackgroundPenninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839 · cited 1×
“A general consensus is that clinical heterogeneity complicates efforts to identify the biological, genetic, and environmental underpinnings of depression [24].”
BackgroundInsulin and neurodegenerative disease: shared and specific mechanisms
Craft, S., & Stennis Watson, G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00681-7 · Cited by 830
Duman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714 · cited 1×
“(PI3K)/Akt pathway and its components, including GSK-3β and mTOR, have been implicated in the response to antidepressants [85].”
BackgroundGender Differences in Treatment Response to Sertraline Versus Imipramine in Chronic Depression
Kornstein, S. G., Schatzberg, A. F., Thase, M. E., Yonkers, K. A., McCullough, J. P., Keitner, G. I., Gelenberg, A. J., Davis, S. M., Harrison, W. M., & Keller, M. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.9.1445 · Cited by 702
Lamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.144 · Cited by 691
Akt/Protein Kinase B Up-regulates Bcl-2 Expression through cAMP-response Element-binding Protein
Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K. A., Boxer, L. M., Heasley, L. E., & Reusch, J. E.-B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10761 · Cited by 679 · cited 4×
“BDNF binds to the TrkB receptor and activates multiple signaling cascades, such as PI3K/Akt pathway and extracellular signal-regulated kinase 1/2 (ERK1/2) pathway [132], which regulate the transcription factor CREB [133,134].”
BackgroundInfluentialRelationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment
Musselman, D. L., Betan, E., Larsen, H., & Phillips, L. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00569-9 · Cited by 671 · cited 1×
“Recent studies suggested that these brain regions may also be related to antidepressant responses [67–70], and some of these brain regions overlapped with those showing a high insulin receptor density and mRNA expression levels [71–74].”
BackgroundThe immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002006 · Cited by 670 · cited 1×
“Activation of this enzyme leads to increased consumption of tryptophan, thus reducing the availability of serotonergic neurotransmission and inducing the production of detrimental tryptophan catabolites with neurotoxic effects [142].”
BackgroundInflammation and clinical response to treatment in depression: A meta-analysis
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.007 · Cited by 666 · cited 1×
“In a recent meta-analysis [39], patients with higher levels of inflammation at baseline responded less well to subsequent treatment, although this finding was not statistically significant.”
BackgroundBrain-immune communication pathways
Quan, N., & Banks, W. A. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.05.005 · Cited by 626 · cited 1×
“Peripheral proinflammatory cytokines cross the blood–brain barrier (BBB) via specific transporters [89].”
BackgroundNelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030312 · Cited by 552 · cited 1×
“Despite the introduction of a number of antidepressant drugs and their prolonged clinical use, many patients with depression show an inadequate response to standard antidepressant therapy [1–4].”
BackgroundZhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549
Moylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529 · cited 1×
“In the depressed state, compromised antioxidant defenses [155] activate oxidative/nitrosative stress pathways and damage to fatty acids, proteins, DNA and mitochondria, and initiate autoimmune responses [156].”
BackgroundKynurenine pathway in major depression: Evidence of impaired neuroprotection
Myint, A.-M., Kim, Y. K., Verkerk, R., Scharpé, S., Steinbusch, H., & Leonard, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.013 · Cited by 527 · cited 2×
“The activity of indoleamine 2–3 dioxygenase (IDO), a catabolizing enzyme of tryptophan and serotonin, was elevated in the plasma of depressed patients and enhanced by a proinflammatory cytokines [141].”
BackgroundAkt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 522 · cited 1×
“In addition, both serotonin and dopamine exert their actions, in part, by modulating Akt/GSK3 activity [108].”
BackgroundSouery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0713 · Cited by 521 · cited 1×
“discussed, there are no reliable predictors of the clinical response to antidepressants [6–8].”
BackgroundXing, J., Kornhauser, J. M., Xia, Z., Thiele, E. A., & Greenberg, M. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1946 · Cited by 496 · cited 4×
“BDNF binds to the TrkB receptor and activates multiple signaling cascades, such as PI3K/Akt pathway and extracellular signal-regulated kinase 1/2 (ERK1/2) pathway [132], which regulate the transcription factor CREB [133,134].”
BackgroundInfluentialSarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486 · cited 1×
“Correlations have been reported between severity of depression and the magnitude of disturbances in oxidative indices [164].”
BackgroundAdipocyte dysfunction, inflammation and metabolic syndrome
Klöting, N., & Blüher, M. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9301-0 · Cited by 472 · cited 1×
“Adipose tissue, as an active endocrine organ, secretes proinflammatory factors, including IL-1, IL-6, TNF-α, and C-reactive protein [87].”
BackgroundAntidepressant-Induced Neurogenesis in the Hippocampus of Adult Nonhuman Primates
Perera, T. D., Coplan, J. D., Lisanby, S. H., Lipira, C. M., Arif, M., Carpio, C., Spitzer, G., Santarelli, L., Scharf, B., Hen, R., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0237-07.2007 · Cited by 460 · cited 1×
“The antidepressant effects of electroconvulsive therapy were accompanied by inducing hippocampal neurogenesis in adult non-human primates [139].”
BackgroundCREB Couples Neurotrophin Signals to Survival Messages
Finkbeiner, S. (2000) · Neuron · doi:10.1016/s0896-6273(00)80866-1 · Cited by 453
c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade
Lee, Y. H., Giraud, J., Davis, R. J., & White, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208359200 · Cited by 438
Inflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis
Gustafson, B., Hammarstedt, A., Andersson, C. X., & Smith, U. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147835 · Cited by 436 · cited 1×
“, leptin, adiponectin, and resistin) [33–35].”
Clinical depression and inflammatory risk markers for coronary heart disease
Miller, G. E., Stetler, C. A., Carney, R. M., Freedland, K. E., & Banks, W. A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02863-1 · Cited by 424 · cited 1×
“Several studies have shown that high levels of proinflammatory cytokines are associated with a reduced responsiveness to antidepressant therapy [97–100] and increased severity of depression [100–102].”
BackgroundCan bipolar disorder be viewed as a multi-system inflammatory disease?
Leboyer, M., Soreca, I., Scott, J., Frye, M., Henry, C., Tamouza, R., & Kupfer, D. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.049 · Cited by 417 · cited 1×
“Obesity may negatively affect prognosis and outcome in depressive disorders through various inflammatory processes [92–96].”
BackgroundGlycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375 · cited 1×
“The PI3K/Akt/GSK3β pathway is also a key mechanism in the regulation of glucose transport and insulin metabolism in insulin-sensitive peripheral tissues [103,113,114].”
BackgroundMaes, M. H. J., Kubera, M., Obuchowiczwa, E., Goehler, L. E., & Brzeszcz, J. (2011) · PubMed · Cited by 374
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A. M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 374 · cited 1×
“In addition, disturbances in neurotransmitter function can lead to increased mood symptoms and to changes in treatment response to medications targeting monoamine neurotransmitters in depressive disorder [146,147].”
BackgroundBlaine, B. (2008) · Journal of Health Psychology · doi:10.1177/1359105308095977 · Cited by 372
Vegeto, E., Benedusi, V., & Maggi, A. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.04.001 · Cited by 355 · cited 2×
“Moreover, estrogen decreases neuroinflammation by modulating microglial activity [43].”
BackgroundANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337 · cited 2×
“Disruption of antidepressant induced hippocampal neurogenesis by selective irradiation of the hippocampus also blocked the antidepressant effects of fluoxetine and imipramine [140], suggesting that neurogenesis is fundamental in determining the functional consequences of antidepressant treatment [138].”
BackgroundGlutamate‐mediated glial injury: Mechanisms and clinical importance
Matute, C., Domercq, M., & Sánchez‐Gómez, M. (2006) · Glia · doi:10.1002/glia.20275 · Cited by 330 · cited 1×
“TNF-α and IL-1 induce both astrocytes and microglia to release reactive oxygen and nitrogen species that amplify oxidative stress and impair glutamine reuptake, which is especially vulnerable to oxidative damage [161,162].”
BackgroundKendler, K. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050025004 · Cited by 323 · cited 1×
“Overall, although there are still insufficient results to allow definitive conclusions to be drawn, the association of atypical features and obesity/excess body weight could be regarded as supported [26,27], and the moderating effect of atypical features on antidepressant responses by obesity/excess body weight was al…”
ResultThe PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications
Weichhart, T., & Säemann, M. D. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.098459 · Cited by 323 · cited 1×
“As PI3K and Akt seem to regulate key inflammatory cytokines resulting in immune cell activation [105], Akt and GSK3 signaling changes may contribute to specific therapeutic effects on depression [106].”
BackgroundMansur, R. B., Brietzke, E., & McIntyre, R. S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.017 · Cited by 322 · cited 4×
“However, the nature of this association remains poorly understood [19], and the mechanisms underlying the potential association between obesity and treatment outcome to antidepressant treatment have not been fully established.”
BackgroundInfluentialSelf-citationKim, J. Y., Duan, X., Liu, C. Y., Jang, M.-H., Guo, J. U., Pow-anpongkul, N., Kang, E., Song, H., & Ming, G.-L. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.008 · Cited by 319 · cited 1×
“Brain intracellular signal transduction systems, including the Akt/GSK3 pathway, have been shown to be altered in patients with psychiatric illness [107].”
BackgroundEstrogen Replacement and Response to Fluoxetine in a Multicenter Geriatric Depression Trial
Schneider, L. S., Small, G. W., Hamilton, S. H., Bystritsky, A., Nemeroff, C. B., & Meyers, B. S. (1997) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700520-00002 · Cited by 298
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Li, X., & Jope, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.105 · Cited by 294 · cited 1×
“GSK3β has been well characterized as a target of the mood stabilizers lithium and antidepressants, which can directly or indirectly block its actions [120].”
BackgroundIncrease in Interleukin-1β in Late-Life Depression
Thomas, A. J., Davis, S., Morris, C., Jackson, E., Harrison, R., & O’Brien, J. T. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.175 · Cited by 291
The role of dopamine in the mechanism of action of antidepressant drugs
D'Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00566-5 · Cited by 289 · cited 1×
“In addition, disturbances in neurotransmitter function can lead to increased mood symptoms and to changes in treatment response to medications targeting monoamine neurotransmitters in depressive disorder [146,147].”
BackgroundGalan, P., Viteri, F. E., Bertrais, S., Czernichow, S., Faure, H., Arnaud, J., Ruffieux, D., Chenal, S., Arnault, N., Favier, A., et al. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602230 · Cited by 284 · cited 1×
“Antioxidants are inversely associated with both obesity [148–150] and MDD [151], and oxidative/nitrosative stress pathways are involved in”
BackgroundEncinas, M., Iglesias, M., Llecha, N., & Comella, J. X. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731409.x · Cited by 278 · cited 1×
“BDNF binds to the TrkB receptor and activates multiple signaling cascades, such as PI3K/Akt pathway and extracellular signal-regulated kinase 1/2 (ERK1/2) pathway [132], which regulate the transcription factor CREB [133,134].”
BackgroundShould Depressive Syndromes Be Reclassified as “Metabolic Syndrome Type II”?
McIntyre, R. S., Soczynska, J. K., Konarski, J. Z., Woldeyohannes, H. O., Law, C. W. Y., Miranda, A., Fulgosi, D., & Kennedy, S. H. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701653377 · Cited by 277 · cited 1×
“As obesity is a core feature of metabolic syndrome [167], the concept of “metabolic-mood syndrome” suggested by some authors [74,168,169] could be expanded to include the association between obesity and antidepressant responses.”
BackgroundSelf-citationThe Concept of Depression as a Dysfunction of the Immune System
E. Leonard, B. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823835 · Cited by 276 · cited 7×
“This was found to be the case for serotonin 1A (5-HT1A) [121] and 5-HT1B [122] receptors, cannabinoid receptor subtype 1 (CB1R) [123], brain-derived neurotropic factor (BDNF) receptor, i.e., tropomyosin receptor kinase B (TrkB) [124–126], and the insulin receptor [104,127,128].”
BackgroundInfluentialMaes, M., Vandoolaeghe, E., Neels, H., Demedts, P., Wauters, A., Meltzer, H. Y., Altamura, C., & Desnyder, R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00365-4 · Cited by 272 · cited 1×
“Moreover, lowered serum levels of antioxidants, such as coenzyme Q10 and zinc, could be biological markers of treatment resistance to antidepressant therapy [153,154].”
BackgroundKullmann, S., Heni, M., Veit, R., Ketterer, C., Schick, F., Häring, H., Fritsche, A., & Preissl, H. (2012) · Human Brain Mapping · doi:10.1002/hbm.21268 · Cited by 271 · cited 1×
“Brain insulin resistance caused by obesity is associated with alterations in neurocircuits and brain regions suggested to be involved in affective disorders [63], including the prefrontal cortex [64,65], amygdala/hippocampus [65], anterior cingulate cortex [66], and ventral striatum [65].”
BackgroundLamers, F., de Jonge, P., Nolen, W. A., Smit, J. H., Zitman, F. G., Beekman, A. T. F., & Penninx, B. W. J. H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05398blu · Cited by 264 · cited 1×
“particular its obesity-related disturbances [25], and show higher inflammatory levels of inflammatory markers [20,21].”
BackgroundSultana, R., Perluigi, M., & Butterfield, D. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2021 · Cited by 262
Morón, J. A., Zakharova, I., Ferrer, J. V., Merrill, G. A., Hope, B., Lafer, E. M., Lin, Z. C., Wang, J. B., Javitch, J. A., Galli, A., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08480.2003 · Cited by 262 · cited 1×
“It has also been shown that the activity of the dopaminergic system is reduced in response to inflammation [143], while cytokines enhance the reuptake of monoamine neurotransmitters, thereby reducing their functionally important intrasynaptic concentrations in the brain [144].”
BackgroundShelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 261 · cited 1×
“Obesity may negatively affect prognosis and outcome in depressive disorders through various inflammatory processes [92–96].”
BackgroundThe CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt
del Pulgar, T. G., Velasco, G., & Guzmán, M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470369 · Cited by 259 · cited 1×
“This was found to be the case for serotonin 1A (5-HT1A) [121] and 5-HT1B [122] receptors, cannabinoid receptor subtype 1 (CB1R) [123], brain-derived neurotropic factor (BDNF) receptor, i.”
BackgroundSex Differences in Antidepressant Response in Recent Antidepressant Clinical Trials
Khan, A., Brodhead, A. E., Schwartz, K. A., Kolts, R. L., & Brown, W. A. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000168879.03169.ce · Cited by 251 · cited 1×
“The results of several studies [45–49], but not all [50,51], support a role of estrogen in modulating serotonergic antidepressant responses.”
ResultImpaired CNS Leptin Action Is Implicated in Depression Associated with Obesity
Yamada, N., Katsuura, G., Ochi, Y., Ebihara, K., Kusakabe, T., Hosoda, K., & Nakao, K. (2011) · Endocrinology · doi:10.1210/en.2011-0004 · Cited by 247 · cited 1×
“Obesity may negatively affect prognosis and outcome in depressive disorders through various inflammatory processes [92–96].”
BackgroundLocalization of function in anterior cingulate cortex: From psychosurgery to functional neuroimaging
Gasquoine, P. G. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.002 · Cited by 239 · cited 1×
“Recent studies suggested that these brain regions may also be related to antidepressant responses [67–70], and some of these brain regions overlapped with those showing a high insulin receptor density and mRNA expression levels [71–74].”
BackgroundToward validation of atypical depression in the community: results of the Zurich cohort study
Angst, J., Gamma, A., Sellaro, R., Zhang, H., & Merikangas, K. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00169-6 · Cited by 239
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Yoshimura, R., Hori, H., Ikenouchi-Sugita, A., Umene-Nakano, W., Ueda, N., & Nakamura, J. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.020 · Cited by 227 · cited 1×
“Several studies have shown that high levels of proinflammatory cytokines are associated with a reduced responsiveness to antidepressant therapy [97–100] and increased severity of depression [100–102].”
BackgroundTargeting PI3 Kinase/AKT/mTOR Signaling in Cancer
Sheppard, K., Kinross, K. M., Solomon, B., Pearson, R. B., & Phillips, W. A. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v17.i1.60 · Cited by 225 · cited 1×
“PI3K pathways regulate metabolism, cell growth, and cell survival [109].”
BackgroundTschritter, O., Preissl, H., Hennige, A. M., Stumvoll, M., Porubska, K., Frost, R., Marx, H., Klösel, B., Lutzenberger, W., Birbaumer, N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604404103 · Cited by 223 · cited 1×
“Brain insulin resistance implies that an increase in insulin levels does not induce an increased neuronal activity in obese individuals in contrast to lean individuals [62].”
BackgroundInflammatory mechanisms in major depressive disorder
Raedler, T. J. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32834b9db6 · Cited by 213 · cited 1×
“Furthermore, the “cytokine hypothesis” of depression could be extended from the development of depression [28] to its clinical course, based on overlapping findings among atypical features (especially neurovegetative symptoms), poor treatment outcome, and obesity in inflammatory and metabolic components related to inf…”
BackgroundWinkler, G., Kiss, S., Keszthelyi, L., Sapi, Z., Ory, I., Salamon, F., Kovacs, M., Vargha, P., Szekeres, O., Speer, G., et al. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490129 · Cited by 213
Overweight and Obesity Affect Treatment Response in Major Depression
Kloiber, S., Ising, M., Reppermund, S., Horstmann, S., Dose, T., Majer, M., Zihl, J., Pfister, H., Unschuld, P. G., Holsboer, F., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.001 · Cited by 208 · cited 3×
“[12] reported a correlation between high BMI and atypicality at baseline.”
BackgroundInfluentialAdipokines oversecreted by omental adipose tissue in human obesity
Maury, E., Ehala-Aleksejev, K., Guiot, Y., Detry, R., Vandenhooft, A., & Brichard, S. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00127.2007 · Cited by 207 · cited 1×
“Visceral adipose tissue from obese subjects has also been shown to secrete higher levels of these proinflammatory adipocytokines compared with non-obese subjects [36–38].”
ResultChrysohoou, C., Panagiotakos, D. B., Pitsavos, C., Skoumas, I., Papademetriou, L., Economou, M., & Stefanadis, C. (2007) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.05.007 · Cited by 199 · cited 1×
“Antioxidants are inversely associated with both obesity [148–150] and MDD [151], and oxidative/nitrosative stress pathways are involved in”
BackgroundLee, C.-C., Huang, C.-C., Wu, M.-Y., & Hsu, K.-S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414112200 · Cited by 198 · cited 1×
“receptor kinase B (TrkB) [124–126], and the insulin receptor [104,127,128].”
BackgroundBDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents
Mai, L., Jope, R. S., & Li, X. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00939.x · Cited by 195 · cited 1×
“receptor kinase B (TrkB) [124–126], and the insulin receptor [104,127,128].”
BackgroundAnthony (2006) · doi:10.2337/db06-0376 · Cited by 195
The associations between psychopathology and being overweight: a 20-year prospective study
HASLER, G., PINE, D. S., GAMMA, A., MILOS, G., AJDACIC, V., EICH, D., RÖSSLER, W., & ANGST, J. (2004) · Psychological Medicine · doi:10.1017/s0033291703001697 · Cited by 192 · cited 1×
“Overall, although there are still insufficient results to allow definitive conclusions to be drawn, the association of atypical features and obesity/excess body weight could be regarded as supported [26,27], and the moderating effect of atypical features on antidepressant responses by obesity/excess body weight was al…”
ResultRoles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses
Kitagishi, Y., Kobayashi, M., Kikuta, K., & Matsuda, S. (2012) · Depression Research and Treatment · doi:10.1155/2012/752563 · Cited by 191 · cited 3×
“As PI3K and Akt seem to regulate key inflammatory cytokines resulting in immune cell activation [105], Akt and GSK3 signaling changes may contribute to specific therapeutic effects on depression [106].”
BackgroundSex differences in response to citalopram: A STAR∗D report
Young, E. A., Kornstein, S. G., Marcus, S. M., Harvey, A. T., Warden, D., Wisniewski, S. R., Balasubramani, G. K., Fava, M., Trivedi, M. H., & John Rush, A. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.07.002 · Cited by 185
Gender differences in antidepressant drug response
Keers, R., & Aitchison, K. J. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.496448 · Cited by 185 · cited 1×
“The different responses may be the result of differential body fat percentage and distribution occurring as a function of obesity and sex, rather than overall body weight [32].”
BackgroundEstrogen augments serotonergic activity in postmenopausal women
Halbreich, U., Rojansky, N., Palter, S., Tworek, H., Hissin, P., & Wang, K. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00181-2 · Cited by 184
Estrogen Replacement and Response to Fluoxetine in a Multicenter Geriatric Depression Trial
Schneider, L. S., Small, G. W., Hamilton, S. H., et al. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199721520-00002 · Cited by 179
DNA damage in bipolar disorder
Andreazza, A. C., Noronha Frey, B., Erdtmann, B., Salvador, M., Rombaldi, F., Santin, A., Gonçalves, C. A., & Kapczinski, F. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.03.025 · Cited by 176 · cited 1×
“[165] found that bipolar disorder is associated with a marked increase in DNA damage in white blood cells due to oxidative stress, and such DNA damage was correlated with the severity of depressive symptoms.”
BackgroundKaestner, F., Hettich, M., Peters, M., Sibrowski, W., Hetzel, G., Ponath, G., Arolt, V., Cassens, U., & Rothermundt, M. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.03.012 · Cited by 176 · cited 2×
“particular its obesity-related disturbances [25], and show higher inflammatory levels of inflammatory markers [20,21].”
BackgroundKullmann, S., Heni, M., Veit, R., Scheffler, K., Machann, J., Häring, H.-U., Fritsche, A., & Preissl, H. (2015) · Diabetes Care · doi:10.2337/dc14-2319 · Cited by 175 · cited 1×
“Brain insulin resistance caused by obesity is associated with alterations in neurocircuits and brain regions suggested to be involved in affective disorders [63], including the prefrontal cortex [64,65], amygdala/hippocampus [65], anterior cingulate cortex [66], and ventral striatum [65].”
BackgroundYu, Y. W. ‐., Chen, T., Hong, C., Chen, H.-M., & Tsai, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300172 · Cited by 172
Rosenblat, J. D., Brietzke, E., Mansur, R. B., Maruschak, N. A., Lee, Y., & McIntyre, R. S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.058 · Cited by 172 · cited 1×
“Furthermore, elevation of inflammatory cytokine levels could induce cognitive and affective dysfunction [171].”
BackgroundSelf-citationRisk factors for treatment resistance in unipolar depression: A systematic review
Bennabi, D., Aouizerate, B., El‐Hage, W., Doumy, O., Molière, F., Courtet, P., Nieto, I., Bellivier, F., Bubrovsky, M., Vaïva, G., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.020 · Cited by 171 · cited 1×
“discussed, there are no reliable predictors of the clinical response to antidepressants [6–8].”
BackgroundMaes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169 · cited 1×
“Oxidative/nitrosative stress pathway activation could be induced by inflammation, which damages lipids, DNA, and proteins, resulting in mitochondrial dysfunction and increased apoptosis, cell membrane damage, and protein aggregation [160].”
BackgroundGreilberger, J., Koidl, C., Greilberger, M., Lamprecht, M., Schroecksnadel, K., Leblhuber, F., Fuchs, D., & Oettl, K. (2008) · Free Radical Research · doi:10.1080/10715760802255764 · Cited by 168 · cited 1×
“Moreover, damage by oxidative/nitrosative stress and subsequent autoimmune responses are major causes of progression and chronicity in MDD [157–159].”
BackgroundHiroi, R., McDevitt, R. A., & Neumaier, J. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.019 · Cited by 162 · cited 1×
“The literature includes evidence supporting the enhanced role of estrogen in the serotonergic system [52–56].”
BackgroundInflammation in depression: is adiposity a cause?
Shelton, R. C., & Miller, A. H. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/rshelton · Cited by 161 · cited 1×
“Local release of cytokines can also stimulate peripheral afferent nerve fibers that innervate peripheral tissues, such as the vagus nerve, ultimately activate microglia to produce cytokines in the brain [91].”
Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2009) · PubMed · Cited by 160
Martényi, F., Dossenbach, M. R. K., Mraz, K., & Metcalfe, S. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00089-x · Cited by 154
Are There Differences Between Women’s and Men’s Antidepressant Responses?
Quitkin, F. M., Stewart, J. W., McGrath, P. J., Taylor, B. P., Tisminetzky, M. S., Petkova, E., Chen, Y., Ma, G., & Klein, D. F. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1848 · Cited by 146 · cited 1×
“The results of several studies [45–49], but not all [50,51], support a role of estrogen in modulating serotonergic antidepressant responses.”
ResultOvarian Steroid Regulation of 5-HT1A Receptor Binding and G protein Activation in Female Monkeys
Lu, N. Z. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00423-7 · Cited by 142 · cited 1×
“The literature includes evidence supporting the enhanced role of estrogen in the serotonergic system [52–56].”
BackgroundStudies of hormone action in the hippocampal formation
McEwen, B. S., Magariños, A. M., & Reagan, L. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00307-0 · Cited by 139 · cited 1×
“In these regions, insulin inhibits the reuptake of norepinephrine, and neuronal firing modulates norepinephrine and dopamine transporter mRNA concentration and catecholamine turnover and stimulates phosphoinositol turnover [74–78].”
BackgroundForkhead Box, Class O Transcription Factors in Brain: Regulation and Behavioral Manifestation
Polter, A. M., Yang, S., Zmijewska, A. A., van Groen, T., Paik, J.-H., DePinho, R. A., Peng, S. L., Jope, R. S., & Li, X. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.005 · Cited by 136 · cited 1×
“Antidepressants, such as fluoxetine and imipramine, and lithium were demonstrated to increase Akt activity [117–119].”
BackgroundVargas, H. O., Nunes, S. O. V., de Castro, M. P., Bortolasci, C. C., Barbosa, D. S., Morimoto, H. K., Venugopal, K., Dodd, S., Maes, M. H. J., & Berk, M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.016 · Cited by 135
Vogelzangs, N., Beekman, A. T., van Reedt Dortland, A. K., Schoevers, R. A., Giltay, E. J., de Jonge, P., & Penninx, B. W. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.9 · Cited by 133 · cited 5×
“Among three studies reporting negative associations between obesity and antidepressant responses, two [16,17] included information regarding the influence of age and sex.”
BackgroundMethodInfluentialLiang, H., Pei, D., Zhang, Q., Guan, Q., & Zhang, G. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.043 · Cited by 127 · cited 1×
“receptor kinase B (TrkB) [124–126], and the insulin receptor [104,127,128].”
BackgroundMaes, M. H. J., Mihaylova, I., Kubera, M., Leunis, J., & Geffard, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.023 · Cited by 124 · cited 1×
“In the depressed state, compromised antioxidant defenses [155] activate oxidative/nitrosative stress pathways and damage to fatty acids, proteins, DNA and mitochondria, and initiate autoimmune responses [156].”
BackgroundWeight gain associated with taking psychotropic medication: An integrative review
McCloughen, A., & Foster, K. (2011) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2010.00721.x · Cited by 121 · cited 1×
“As obesity is a core feature of metabolic syndrome [167], the concept of “metabolic-mood syndrome” suggested by some authors [74,168,169] could be expanded to include the association between obesity and antidepressant responses.”
BackgroundThe effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder
Yim, C. Y., Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Brietzke, E. M., & McIntyre, R. S. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.004 · Cited by 117 · cited 1×
“For example, evidence suggests that neurocognitive dysfunction, considered a core feature of mood disorders, is more prominent in overweight/obese individuals with mood disorders [170].”
BackgroundSelf-citationEffect of Long‐Lasting Diabetes Mellitus on Rat and Human Brain Monoamines
Lacković, Z., Šlković, M., Kuçi, Z., & Relja, M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb13294.x · Cited by 116 · cited 1×
“Furthermore, insulin disturbance may affect the metabolism of brain monoamines and expression of serotonergic receptors in diabetic animal models and humans [79–83].”
BackgroundKENDALL, D., Stancel, G. M., & Enna, S. (1982) · Journal of Neuroscience · doi:10.1523/jneurosci.02-03-00354.1982 · Cited by 115 · cited 1×
“The literature includes evidence supporting the enhanced role of estrogen in the serotonergic system [52–56].”
BackgroundJun, T., Pae, C., Hoon-Han, Chae, J., Bahk, W., Kim, K., & Serretti, A. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200309000-00008 · Cited by 115 · cited 1×
“Several studies have shown that high levels of proinflammatory cytokines are associated with a reduced responsiveness to antidepressant therapy [97–100] and increased severity of depression [100–102].”
BackgroundSelf-citationGirgis, R. R., Javitch, J. A., & Lieberman, J. A. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.40 · Cited by 113 · cited 1×
“This pathway has emerged as a mediator of antidepressant effects of commonly used psychotropic agents [116].”
BackgroundTherapeutic options in treatment-resistant depression
Vieta, E., & Colom, F. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.583675 · Cited by 112 · cited 1×
“Despite the introduction of a number of antidepressant drugs and their prolonged clinical use, many patients with depression show an inadequate response to standard antidepressant therapy [1–4].”
BackgroundGiacobbe, P., Mayberg, H. S., & Lozano, A. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.028 · Cited by 112 · cited 1×
“Recent studies suggested that these brain regions may also be related to antidepressant responses [67–70], and some of these brain regions overlapped with those showing a high insulin receptor density and mRNA expression levels [71–74].”
BackgroundNeural–immune interface in the rat area postrema
Goehler, L. E., Erişir, A., & Gaykema, R. P. A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.048 · Cited by 109 · cited 1×
“, at circumventricular organs [90].”
Kemp, D. E., Ismail-Beigi, F., Ganocy, S. J., Conroy, C., Gao, K., Obral, S., Fein, E., Findling, R. L., & Calabrese, J. R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.033 · Cited by 109 · cited 1×
“Obesity may negatively affect prognosis and outcome in depressive disorders through various inflammatory processes [92–96].”
BackgroundIda, T., Hara, M., Nakamura, Y., Kozaki, S., Tsunoda, S., & Ihara, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.047 · Cited by 107 · cited 1×
“TNF-α and IL-1 induce both astrocytes and microglia to release reactive oxygen and nitrogen species that amplify oxidative stress and impair glutamine reuptake, which is especially vulnerable to oxidative damage [161,162].”
BackgroundBody weight as a predictor of antidepressant efficacy in the GENDEP project
Uher, R., Mors, O. N., Hauser, J., Rietschel, M., Maier, W., Kozel, D., Henigsberg, N., Souery, D., Placentino, A., Perroud, N. A., et al. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.013 · Cited by 107 · cited 7×
“[18] 12-week, open-label, part-randomized trial DSM-IV MDD, at least moderate severity Mean age = 42.”
BackgroundInfluentialLener, M. S., & Iosifescu, D. V. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12759 · Cited by 105
FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling
Zheng, W., Kar, S., & Quirion, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00783.x · Cited by 102
Vogelzangs, N., Beekman, A. T. F., Boelhouwer, I. G., Bandinelli, S., Milaneschi, Y., Ferrucci, L., & Penninx, B. W. J. H. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06559 · Cited by 100 · cited 1×
“As obesity is a core feature of metabolic syndrome [167], the concept of “metabolic-mood syndrome” suggested by some authors [74,168,169] could be expanded to include the association between obesity and antidepressant responses.”
BackgroundObesity among outpatients with Major Depressive Disorder
Papakostas, G. I., Petersen, T., Iosifescu, D. V., Burns, A. M., Nierenberg, A. A., Alpert, J. E., Rosenbaum, J. F., & D, M. F. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004602 · Cited by 97 · cited 2×
“[10] investigated 369 adult outpatients with major depressive disorder (MDD) and a 17-item Hamilton Depression Rating Scale (HAMD) score of ě16 at baseline.”
BackgroundPinto‐Meza, A., Usall, J., Serrano‐Blanco, A., Suarez, D. L., & Haro, J. M. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.010 · Cited by 97
Potential surgical targets for deep brain stimulation in treatment-resistant depression
Hauptman, J. S., DeSalles, A. A. F., Espinoza, R. T., Sedrak, M. F., & Ishida, W. (2008) · Neurosurgical FOCUS · doi:10.3171/foc/2008/25/7/e3 · Cited by 93 · cited 1×
“Recent studies suggested that these brain regions may also be related to antidepressant responses [67–70], and some of these brain regions overlapped with those showing a high insulin receptor density and mRNA expression levels [71–74].”
BackgroundŽegura, B., Gužič‐Salobir, B., Šebeštjen, M., & Keber, I. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000198485.70703.7a · Cited by 91 · cited 1×
“Studies in postmenopausal women have shown a reversal of increased adipocytokines caused by increased visceral adiposity during menopause [40] with repletion of estrogen [41,42] and a specific anti-inflammatory action of estrogen on the brain [43,44].”
BackgroundPredictors of response to antidepressants
Nierenberg, A. A. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00105-3 · Cited by 91 · cited 1×
“Moreover, predictors of responses to specific antidepressants or within a specific population are also needed to allow appropriate treatment planning in individual cases [5].”
BackgroundRisk factors of treatment resistance in major depression: Association with bipolarity
Dudek, D., RYBAKOWSKI, J. K., Siwek, M., Pawłowski, T., Łojko, D., Roczeń, R., & Kiejna, A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.001 · Cited by 90 · cited 1×
“discussed, there are no reliable predictors of the clinical response to antidepressants [6–8].”
BackgroundEstrogen receptor-β regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe
Gundlah, C., Alves, S. E., Clark, J. A., Pai, L.-Y., Schaeffer, J. M., & Rohrer, S. P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.014 · Cited by 85 · cited 1×
“The literature includes evidence supporting the enhanced role of estrogen in the serotonergic system [52–56].”
BackgroundGender differences in response to differing antidepressant drug classes: two negative studies
Parker, G. B., Parker, G. B., Austin, M., Mitchell, P. B., & Brotchie, H. (2003) · Psychological Medicine · doi:10.1017/s0033291703007918 · Cited by 82 · cited 1×
“The results of several studies [45–49], but not all [50,51], support a role of estrogen in modulating serotonergic antidepressant responses.”
ResultObesity Comorbidity in Unipolar Major Depressive Disorder
Levitan, R. D., Davis, C., Kaplan, A. S., Arenovich, T., Phillips, D. I. W., & Ravindran, A. V. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07394 · Cited by 81 · cited 1×
“As obesity is a core feature of metabolic syndrome [167], the concept of “metabolic-mood syndrome” suggested by some authors [74,168,169] could be expanded to include the association between obesity and antidepressant responses.”
BackgroundBenedetti, F., Lucca, A., Brambilla, F., Colombo, C., & Smeraldi, E. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00255-5 · Cited by 81 · cited 1×
“Several studies have shown that high levels of proinflammatory cytokines are associated with a reduced responsiveness to antidepressant therapy [97–100] and increased severity of depression [100–102].”
BackgroundAge of menopause in Japanese women: trends and recent changes
Kono, S., Sunagawa, Y., Higa, H., & Sunagawa, H. (1990) · Maturitas · doi:10.1016/0378-5122(90)90059-f · Cited by 76 · cited 1×
“Since the mean age at menopause is approximately 50 years [60], and the mean age of the subjects in the abovementioned studies was early 40s, it is possible that a large portion of subjects were premenopausal women, which may have increased the likelihood of a negative association between obesity and a poor response t…”
BackgroundLione, A. M., Errico, M., Lin, S. L., & Cowen, D. S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750934.x · Cited by 73
Bengesser, S., Lackner, N., Birner, A., Fellendorf, F. T., Platzer, M., Mitteregger, A., Unterweger, R., Reininghaus, B., Mangge, H., Wallner-Liebmann, S. J., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.014 · Cited by 70 · cited 1×
“, neoepitopes [163].”
Self-citationPI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis
Okumura, N., Yoshida, H., Kitagishi, Y., Murakami, M., Nishimura, Y., & Matsuda, S. (2012) · Advances in Hematology · doi:10.1155/2012/843085 · Cited by 69
A Neural Circuitry Linking Insulin Resistance to Depressed Mood
Ryan, J. P., Sheu, L. K., Critchley, H. D., & Gianaros, P. J. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31824d0865 · Cited by 68 · cited 1×
“Brain insulin resistance caused by obesity is associated with alterations in neurocircuits and brain regions suggested to be involved in affective disorders [63], including the prefrontal cortex [64,65], amygdala/hippocampus [65], anterior cingulate cortex [66], and ventral striatum [65].”
BackgroundCowen, D. S., Johnson-Farley, N. N., & Travkina, T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03107.x · Cited by 67 · cited 1×
“This was found to be the case for serotonin 1A (5-HT1A) [121] and 5-HT1B [122] receptors, cannabinoid receptor subtype 1 (CB1R) [123], brain-derived neurotropic factor (BDNF) receptor, i.”
BackgroundAssociations between obesity and serum lipid-soluble micronutrients among premenopausal women
Chai, W., Conroy, S. M., Maskarinec, G., Franke, A. A., Pagano, I., & Cooney, R. V. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.04.006 · Cited by 64 · cited 1×
“Antioxidants are inversely associated with both obesity [148–150] and MDD [151], and oxidative/nitrosative stress pathways are involved in”
BackgroundJohnson-Farley, N. N., Travkina, T., & Cowen, D. S. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094433 · Cited by 63 · cited 1×
“receptor kinase B (TrkB) [124–126], and the insulin receptor [104,127,128].”
BackgroundSandrini, M., Vitale, G., Vergoni, A. V., Ottani, A., & Bertolini, A. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00084-2 · Cited by 63 · cited 1×
“Furthermore, insulin disturbance may affect the metabolism of brain monoamines and expression of serotonergic receptors in diabetic animal models and humans [79–83].”
BackgroundBMI, sex, and antidepressant response
Khan, A., Schwartz, K. A., Kolts, R. L., & Brown, W. A. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.027 · Cited by 62 · cited 3×
“A poor response has been associated with obesity in men treated with serotonergic antidepressants [11] and noradrenergic antidepressants, but not in either sex treated with serotonergic antidepressants [18] or post-menopausal women treated primarily with SSRIs or SNRIs in our preliminary experiments.”
BackgroundMethodLiu, C., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130204031 · Cited by 61 · cited 1×
“Furthermore, the “cytokine hypothesis” of depression could be extended from the development of depression [28] to its clinical course, based on overlapping findings among atypical features (especially neurovegetative symptoms), poor treatment outcome, and obesity in inflammatory and metabolic components related to inf…”
BackgroundSelf-citationDaniele, S., Pozzo, E. D., Zappelli, E., & Martini, C. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.006 · Cited by 60
Insulin receptors and insulin action in dissociated brain cells
Masters, B. A., Shemer, J., Judkins, J. H., Clarke, D. W., Roith, D. L., & Raizada, M. K. (1987) · Brain Research · doi:10.1016/0006-8993(87)90449-5 · Cited by 59 · cited 1×
“In these regions, insulin inhibits the reuptake of norepinephrine, and neuronal firing modulates norepinephrine and dopamine transporter mRNA concentration and catecholamine turnover and stimulates phosphoinositol turnover [74–78].”
BackgroundToups, M. S. P., Myers, A. K., Wisniewski, S. R., Kurian, B., Morris, D. W., Rush, A. J., Fava, M., & Trivedi, M. H. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000000 · Cited by 59 · cited 4×
“[16] reported that atypical features were more common in high-BMI subjects, and melancholic features were more common in low-BMI subjects, consistent with the diagnostic criteria of increased and decreased appetite, respectively, for these subtypes.”
BackgroundResultInfluentialWhich Measures of Obesity Are Related to Depressive Symptoms and in Whom?
Lim, W., Thomas, K. S., Bardwell, W. A., & Dimsdale, J. E. (2008) · Psychosomatics · doi:10.1176/appi.psy.49.1.23 · Cited by 59 · cited 1×
“The results of epidemiological studies indicated the effects of sex on the association between body weight and treatment outcome [30,31].”
BackgroundDoes estrogen enhance the antidepressant effects of fluoxetine?
Tam, L. W., & Parry, B. L. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00357-9 · Cited by 56 · cited 1×
“In preclinical and clinical studies, estrogen administration enhanced the antidepressant effect of SSRIs [57–59].”
BackgroundEstradiol–sertraline synergy in ovariectomized rats
Sell, S. L., Craft, R. M., Seitz, P. K., Stutz, S. J., Cunningham, K. A., & Thomas, M. L. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.05.006 · Cited by 55 · cited 1×
“In preclinical and clinical studies, estrogen administration enhanced the antidepressant effect of SSRIs [57–59].”
BackgroundHippocampal GSK3β as a Molecular Link Between Obesity and Depression
Papazoglou, I., Jean, A., Gertler, A., Taouis, M., & Vacher, C. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8863-x · Cited by 54 · cited 1×
“The serine/threonine kinase GSK3β plays roles in the regulation of many brain functions, including the control of energy homeostasis and mood [115].”
BackgroundShibata, S., Liou, S. Y., Ueki, S., & Oomura, Y. (1986) · Physiology & Behavior · doi:10.1016/0031-9384(86)90077-6 · Cited by 52 · cited 1×
“In these regions, insulin inhibits the reuptake of norepinephrine, and neuronal firing modulates norepinephrine and dopamine transporter mRNA concentration and catecholamine turnover and stimulates phosphoinositol turnover [74–78].”
BackgroundHe, G., Pedersen, S. B., Bruun, J. M., Lihn, A. S., Jensen, P. F., & Richelsen, B. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-39078 · Cited by 52
Huang, W. C., Zhao, Y. C., Zhu, X., Cai, Z., Wang, S., Yao, S., Qi, Z., & Xie, P. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9822-5 · Cited by 52 · cited 1×
“Antidepressants, such as fluoxetine and imipramine, and lithium were demonstrated to increase Akt activity [117–119].”
BackgroundАнатольевич, П. И., Cline, B. H., Anthony, D. C., Steinbusch, H. W. M., Lesch, K., & Strekalova, T. V. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.049 · Cited by 48
Lithium Reduces FoxO3a Transcriptional Activity by Decreasing Its Intracellular Content
Mao, Z., Liu, L., Zhang, R., & Li, X. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.006 · Cited by 43 · cited 1×
“Antidepressants, such as fluoxetine and imipramine, and lithium were demonstrated to increase Akt activity [117–119].”
BackgroundBody Mass Index and Response to Antidepressants in Depressed Research Subjects
Oskooilar, N., Wilcox, C. S., Tong, M.-L., & Grosz, D. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09l05226blu · Cited by 41 · cited 2×
“[13] performed a meta-analysis on data from three completed clinical trials of MDD patients using an 8-week, double-blind, active-controlled comparison design.”
MethodMansoor, B., Rengasamy, M. L., Hilton, R., Porta, G., He, J., Spirito, A., Emslie, G. J., Mayes, T. L., Clarke, G. N., Wagner, K. D., et al. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0095 · Cited by 40 · cited 1×
“In contrast to the above results, a study of adolescent TRD subjects [61] did not support different effects of BMI on treatment response to different antidepressant classes.”
ResultEffects of short and long-lasting diabetes mellitus on mouse brain monoamines
Chen, C., & Yang, J.-C. (1991) · Brain Research · doi:10.1016/0006-8993(91)90677-n · Cited by 38 · cited 1×
“Furthermore, insulin disturbance may affect the metabolism of brain monoamines and expression of serotonergic receptors in diabetic animal models and humans [79–83].”
BackgroundShould mood reactivity be included in the DSM-IV atypical features specifier?
Benazzi, F. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0373-6 · Cited by 38 · cited 2×
“The Netherlands Study of Depression and Anxiety (NESDA) [23].”
BackgroundDennehy, E. B., Robinson, R. L., Stephenson, J. J., Faries, D., Grabner, M., Palli, S. R., Stauffer, V. L., & Marangell, L. B. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1029893 · Cited by 37 · cited 5×
“[14] analyzed data from a cohort of subjects with depressive disorders over a 6-month follow-up.”
BackgroundMethodInfluentialŠagud, M., Mihaljević-Peleš, A., Uzun, S., Ćusa, B. V., Kozumplik, O., Mikulić, S. K., Mustapić, M., Barišić, I., Mück‐Šeler, D., & Pivac, N. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3085-x · Cited by 34
Li, J., & France, C. P. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328308f1d6 · Cited by 33 · cited 1×
“Furthermore, insulin disturbance may affect the metabolism of brain monoamines and expression of serotonergic receptors in diabetic animal models and humans [79–83].”
BackgroundMichaliszyn, S. F., Soreca, I., Otto, A. D., Jakicic, J. M., Fagiolini, A. M., Kupfer, D. J., & Goodpaster, B. H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1207 · Cited by 32 · cited 1×
“, macrophages) [111,112].”
Turner, P., Kantaria, R., & Young, A. H. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113507640 · Cited by 31 · cited 1×
“Despite the introduction of a number of antidepressant drugs and their prolonged clinical use, many patients with depression show an inadequate response to standard antidepressant therapy [1–4].”
BackgroundBroderick, P. A., & Jacoby, J. H. (1989) · PubMed · Cited by 28
Mueck, A. O., Genazzani, A. R., Samsioe, G., Vukovic-Wysocki, I., & Seeger, H. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318054e2e7 · Cited by 25
Yanagita, T., Nemoto, T., Satoh, S., Yoshikawa, N., Maruta, T., Shiraishi, S., Sugita, C., & Murakami, M. (2013) · InTech eBooks · doi:10.5772/54389 · Cited by 18 · cited 1×
“The association between insulin signal impairment and antidepressant effects can be explained by the role of insulin signaling molecules, including glycogen synthase (GSK)-3β, mammalian target of rapamycin (mTOR), protein kinase B (Akt), and extracellular signal-regulated kinase (ERK) 1/2 [84].”
BackgroundArlt, S., Kontush, A., Müller‐Thomsen, T., & Beisiegel†, U. (2001) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s003910170019 · Cited by 14
Role of metabolic dysfunction in treatment resistance of major depressive disorder
Toups, M. S., & Trivedi, M. H. (2011) · Neuropsychiatry · doi:10.2217/npy.11.49 · Cited by 9 · cited 1×
“Among the possible predictors of treatment response in depressive disorder, obesity may contribute to a poor treatment response [9].”
Background
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Self-citationAmare, A. T., Schubert, K. O., Klingler-Hoffmann, M., Cohen-Woods, S., & Baune, B. T. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.261 · Cited by 345
Effects of obesity on depression: A role for inflammation and the gut microbiota
Schachter, J., Martel, J., Lin, C.-S., Chang, C.-J., Wu, T.-R., Lu, C.-C., Ko, Y.-F., Lai, H.-C., Ojcius, D. M., & Young, J. D. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.08.026 · Cited by 253
“sion respond poorly to therapy, suggesting that obesity may reduce the efficacy of anti-depression treatment (Woo et al., 2016).”
BackgroundRole of Adiposity-Driven Inflammation in Depressive Morbidity
Capuron, L., Lasselin, J., & Castanon, N. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.123 · Cited by 182
“…(de Wit et al, 2010; Kasen et al, 2008; Ma and Xiao, 2010; Simon et al, 2008) and to predict recurrence of depressive episodes as well as antidepressant non-response in depressed patients (Kloiber et al, 2007; Nigatu et al, 2015; Oskooilar et al, 2009; Rizvi et al, 2014; Woo et al, 2016).”
BackgroundKetogenic diet as a metabolic therapy for mood disorders: Evidence and developments
Brietzke, E., Mansur, R. B., Subramaniapillai, M., Balanzá-Martínez, V., Vinberg, M., González-Pinto, A., Rosenblat, J. D., Ho, R., & McIntyre, R. S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.020 · Cited by 173
Self-citation
Metadata
- Authors
- Woo, Y., Seo, H.-J., McIntyre, R., & Bahk, W.-M.
- Affiliations
- University Health Network (CA)
- Catholic University of Korea (KR)
- Corresponding author
- Bahk, Won-Myong
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-01-12
- Volume
- 17
- Issue
- 1
- Pages
- 80
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC4730324
- OpenAlex
- W2237079496
- Cited by
- 79
- References
- 177
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 4 · 2023: 9 · 2022: 7 · 2021: 9 · 2020: 10 · 2019: 13 · 2018: 6 · 2017: 6 · 2016: 4
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Brain and Behavior Research Foundation
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Sunovion
- H. Lundbeck A/S
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Keywords
- obesity, depressive disorders, antidepressant response, overweight, sex differences, menopausal status, inflammatory markers, neuropsychological performance, antidepressant efficacy
- MeSH terms
- Adult, Age Factors, Antidepressive Agents, Clinical Trials as Topic, Depressive Disorder, Female, Humans, Male, Middle Aged, Obesity, Prognosis, Sex Factors, Body Mass Index, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.